A Guide for Efficacious Data Integrity During COVID-19
Learn how ProPharma implements data integrity measures to prevent reputation damage, unsafe products, and costs.With the current pandemic creating schedule delays, interrupting supply chains, and reducing margins, it’s more important than ever that companies are able to trust their data for better quality decision making.
This whitepaper provides guidance for ensuring data integrity through COVID-19 and after, including insights about:
- How MHRA inspectors approach your employees and assess your company
- Why company culture is such a critical – yet often overlooked – component of data integrity
- Finding gaps in your data integrity plan using 4 key steps
- Using the acronym “ALCOA” to provide a framework for additional questions
- Preparing a proper data integrity approach using only 2 phases
Whitepapers
Related Resources
Infographic
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Infographic
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Infographic
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...